Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
General and dedicated cancer emergency room: Clinical and financial implicationsMalavasi, N. ; Fiorani, C. ; Ferrara, L. ; Postiglione, R. ; Scarabelli, L. ; Cantile, F. ; Saviola, A. ; Longo, G. ; Luciani, A. ; Cascinu, S.Annals of oncology, 2018-10, Vol.29, p.viii623-viii623 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
A novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicineSaviola, A. ; Cascinu, S. ; Salati, M. ; Longo, G. ; Fiorani, C. ; Ferrara, L. ; Malavasi, N. ; Postiglione, R. ; Cantile, F. ; Scarabelli, L. ; Rimini, M. ; Ferri, F.Annals of oncology, 2018-10, Vol.29, p.viii554-viii554 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)Martini, G. ; Belli, V. ; Vitiello, P.P. ; Troiani, T. ; Cardone, C. ; Napolitano, S. ; Desiderio, V. ; Sforza, V. ; Ferrara, M.L. ; Papaccio, G. ; Mele, L. ; Liguori, G. ; Botti, G. ; Franco, R. ; Morgillo, F. ; Ciardiello, F. ; Martinelli, E.Annals of oncology, 2016-10, Vol.27, p.vi1-vi1 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
HER2 activation and epithelial-mesenchymal transition (EMT) are involved in the acquired resistance to cetuximab in combination with either regorafenib or refametinibVitiello, P.P. ; Martini, G. ; Belli, V. ; Cardone, C. ; Sforza, V. ; Ferrara, M.L. ; Napolitano, S. ; Della Corte, C.M. ; Zanaletti, N. ; Vitale, P. ; Pompella, L. ; Morgillo, F. ; Troiani, T. ; Ciardiello, F. ; Martinelli, E.Annals of oncology, 2016-10, Vol.27, p.vi4-vi4 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
AXL activation can promote resistance to MEK inhibition in a model of colorectal cancer (CRC)Martini, G. ; Belli, V. ; Vitiello, P.P. ; Troiani, T. ; Cardone, C. ; Napolitano, S. ; Sforza, V. ; Ferrara, M.L. ; Morgillo, F. ; Ciardiello, D. ; Giunta, E.F. ; Ciardiello, F. ; Martinelli, E.Annals of oncology, 2016-10, Vol.27, p.vi8-vi8 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Transforming growth factor beta receptor (TGF&bgr;R) pathway is involved in ligand independent transactivation of AXL receptor in colorectal cancer (CRC) cell linesFranzese, E. ; Martini, G. ; Cardone, C. ; Troiani, T. ; Sforza, V. ; Ferrara, M.L. ; Belli, V. ; Vitiello, P.P. ; Napolitano, S. ; Zanaletti, N. ; Vitale, P. ; De Vita, F. ; Orditura, M. ; Morgillo, F. ; Ciardiello, F. ; Martinelli, E.Annals of oncology, 2016-10, Vol.27, p.vi8-vi8 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
1745PGeneral and dedicated cancer emergency room: Clinical and financial implicationsMalavasi, N ; Fiorani, C ; Ferrara, L ; Postiglione, R ; Scarabelli, L ; Cantile, F ; Saviola, A ; Longo, G ; Luciani, A ; Cascinu, SAnnals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
8 |
Material Type: Artigo
|
1533PA novel electronic tool to implement palliative sedation (PS) in a department of oncologic medicineSaviola, A ; Cascinu, S ; Salati, M ; Longo, G ; Fiorani, C ; Ferrara, L ; Malavasi, N ; Postiglione, R ; Cantile, F ; Scarabelli, L ; Rimini, M ; Ferri, FAnnals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
9 |
Material Type: Artigo
|
Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)Ferrara, R. ; Naigeon, M. ; Auclin, E. ; Duchemann, B. ; Cassard, L. ; Medhi, J. ; Boselli, L. ; Grivel, J. ; Desnoyer, A. ; Mezquita, L. ; Aboubakar, F. ; Hendriks, L. ; Planchard, D. ; Caramella, C. ; Remon, J. ; Ngocamus, M. ; Nicotra, C. ; Besse, B. ; Chaput, N.Annals of oncology, 2018-10, Vol.29, p.viii511-viii511 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts)Ferrara, R. ; Naigeon, M. ; Auclin, E. ; Duchemann, B. ; Cassard, L. ; Medhi, J.J. ; Boselli, L. ; Grivel, J. ; Desnoyer, A. ; Mezquita, L. ; Hendriks, L. ; Planchard, D. ; Caramella, C. ; Remon-Masip, J. ; Sangaletti, S. ; Garassino, M.C. ; Besse, B. ; Chaput, N.Annals of oncology, 2019-04, Vol.30, p.ii7-ii8 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |